Abnormal expression of miR‐1 in breast carcinoma as a potent prognostic factor

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|11|1642-1650

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.11, 2015-11, pp. : 1642-1650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR‐181a induces sorafenib resistance of hepatocellular carinoma cells through downregulation of RASSF1 expression

By  

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1256-1262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long non‐coding RNA Fer‐1‐like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR‐106a‐5p in colon cancer

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1323-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients

By  

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 819-824

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of MAS1 in breast cancer

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1240-1248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of MAS1 in breast cancer

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1240-1248

John Wiley & Sons Inc

Access to resources Recommend Favorite